obesity glp-1 news today How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 New research is challenging long-held

Novo Nordisk CEO Lars Fruergaard Jrgensen said this March that the gap between demand for weight loss drugs and the supply is significant enough to take years to close

Therefore, we sought to review the current literature to better understand the mechanisms of action, clinical application, and person-centred considerations of GLP-1RAs in kidney transplant recipients

Arch Intern Med, 2006

Anyone looking for a GLP-1 alternative or weight loss pill this is not that

Some studies have shown small reductions in total cholesterol, LDL cholesterol, and triglycerides in certain patients, though these medications are not substitutes for statins when lipid-lowering therapy is indicated

Flow Wellness offers a variety of weight loss medication options, including tirzepatide, semaglutide, oral GLP-1 medications, and brand-name medications when appropriate